What is Provectus Biopharmaceuticals Inc?
, a clinical-stage biotechnology company, engages in developing immunotherapy medicines for various diseases in the United States.
The story behind the price, the case for and against, and what could go wrong. Open a part to read it.
, a clinical-stage biotechnology company, engages in developing immunotherapy medicines for various diseases in the United States. The company's lead molecule is rose bengal sodium, a member of a class of molecules called halogenated xanthenes. The company is listed on the OTCQB in USA, operating in the Healthcare sector, with a market capitalisation of 19.75M.
A short list of Biotechnology names that are close enough in size to make side-by-side comparison useful.